New studies published on formaldehyde health effects
ToxStrategies scientists Dr. Chad Thompson, Dr. Allison Franzen, and Ms. Seneca Fitch and their colleagues have published a pair of papers in a special issue of Critical Reviews in… read more
Latest News
Dr. Laurie Haws on Science Panel at ARA workshop
Dr. Laurie Haws will be participating on the Science Panel at the upcoming Alliance for Risk Assessment (ARA) workshop, Beyond Science & Decisions: From Problem Formulation to Dose-Response Assessment. The… read more
ToxStrategies partners with Feeding America
ToxStrategies is pleased to announce that we are partnering with Feeding America to help provide food to the millions of Americans currently in need. Feeding… read more
New review paper on risk assessment of dioxin-like compounds
ToxStrategies scientists have developed a range of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on application of systematic review methods and quantitative integration… read more
ToxStrategies presents at SRA 2020
ToxStrategies is excited to be participating in the Society for Risk Analysis (SRA)’s 2020 Annual Meeting, which will be held virtually December 13-17th. We have two virtual poster presentations this year. Camarie… read more
EpidStrategies participating in ASH 2020
EpidStrategies is excited to be participating in the American Society of Hematology (ASH) Annual Meeting, which will be held virtually on December 5-8, 2020. Xiaohui Jiang and… read more
ToxStrategies scientists and colleagues publish new AOP study
ToxStrategies scientists Dr. Mark Harris, Dr. Deborah Proctor, and Dr. Chad Thompson are among the authors of a recently published study that proposes a cytotoxicity-mediated adverse outcome… read more
UK toxicologist joins ToxStrategies
ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a… read more